Edition:
United Kingdom

Nabriva Therapeutics PLC (NBRV.OQ)

NBRV.OQ on NASDAQ Stock Exchange Global Select Market

5.49USD
8:59pm GMT
Change (% chg)

$-0.12 (-2.14%)
Prev Close
$5.61
Open
$5.65
Day's High
$5.67
Day's Low
$5.46
Volume
33,191
Avg. Vol
153,513
52-wk High
$14.09
52-wk Low
$4.56

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 1.47 -0.791
Jun '17 1.05 -0.537
Mar '17 1.68 -5.596
FY 2016 Dec '16
Sep '16 0.97 -0.658
Jun '16 1.78 -0.570
Mar '16 1.42 -6.421
FY 2015 Dec '15 3.77 -23.706
Sep '15 0.00 -4.154
Jun '15 0.00 -2.966
Mar '15 0.00 -4.981
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 6 1.40 1.80 1.00 0.57
Quarter Ending Mar-18 4 1.62 2.30 1.00 --
Year Ending Dec-17 6 5.60 6.00 5.20 3.54
Year Ending Dec-18 6 5.67 9.50 2.90 3.70
Earnings (per share)
Quarter Ending Dec-17 6 -0.57 -0.48 -0.62 -0.59
Quarter Ending Mar-18 4 -0.57 -0.48 -0.63 --
Year Ending Dec-17 5 -2.61 -2.46 -3.06 -2.74
Year Ending Dec-18 6 -2.31 -1.85 -2.86 -12.22
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 88.65 32.93
P/E High - Last 5 Yrs. -- 290.75 45.62
P/E Low - Last 5 Yrs. -- 93.66 24.34
Beta -- 0.85 0.88
Price to Sales (TTM) 50.61 100.67 5.40
Price to Book (MRQ) 0.46 13.50 5.38
Price to Tangible Book (MRQ) 6.16 13.43 6.78
Price to Cash Flow (TTM) -- 76.23 23.45
% Owned Institutions 61.24 6.25 1.40

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.50
Dividend Yield - 5 Year Avg -- 0.28 1.52
Dividend 5 Year Growth Rate -- 1.88 5.17
Payout Ratio(TTM) -- 17.26 43.76

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -41.12 433.84 9.00
Sales (TTM) vs TTM 1 Yr. Ago -13.83 75.03 5.38
Sales - 5 Yr. Growth Rate -- 33.47 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago 5.69 30.81 19.67
EPS (TTM) vs TTM 1 Yr. Ago -8.57 -- --
EPS - 5 Yr. Growth Rate -- 43.17 10.79
Capital Spending - 5 Yr. Growth Rate -- 40.71 15.25

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.68 2.18
Current Ratio (MRQ) 3.77 5.36 2.98
LT Debt to Equity (MRQ) 0.44 18.92 11.56
Total Debt to Equity (MRQ) 0.44 20.59 15.81
Interest Coverage (TTM) -2.14 -112.49 33.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -290.58 38.73 54.83
Gross Margin - 5 Yr. Avg. -- 51.18 52.40
EBITD Margin (TTM) -987.15 -- --
EBITD - 5 Yr. Avg -- -261.11 15.24
Operating Margin (TTM) -991.86 -556.64 7.76
Operating Margin - 5 Yr. Avg. -- -279.29 10.75
Pre-Tax Margin (TTM) -1,003.38 -529.88 8.57
Pre-Tax Margin - 5 Yr. Avg. -- -279.02 11.17
Net Profit Margin (TTM) -982.39 -531.33 4.88
Net Profit Margin - 5 Yr. Avg. -- -282.20 7.47
Effective Tax Rate (TTM) -- 23.72 23.11
Effective Tax Rate - 5 Yr. Avg. -- 19.13 24.00

Efficiency

  Company industry sector
Revenue/Employee (TTM) 101,814 25,314,503 864,673,362
Net Income/Employee (TTM) -1,000,203 3,332,048 101,717,513
Receivable Turnover (TTM) 0.73 21.54 5.76
Inventory Turnover (TTM) -- 2.01 3.34
Asset Turnover (TTM) 0.07 0.37 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -72.01 -0.78 11.00
Return on Assets - 5 Yr. Avg. -- -0.26 12.43
Return on Investment (TTM) -87.80 2.35 14.46
Return on Investment - 5 Yr. Avg. -- 2.98 16.28
Return on Equity (TTM) -88.10 2.95 16.05
Return on Equity - 5 Yr. Avg. -- 6.40 17.51
  1 Year 3 Year 5 Year
Sales % 72.07 -- --
EPS (TTM) % -7.80 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Nabriva Therapeutics PLC

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -5.25 -8.52 26 53
13 Week -20.95 -24.80 20 61
26 Week -24.27 -30.03 27 69
52 Week 15.92 -1.75 62 46
YTD 39.26 22.30 71 50
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 67.69%
# of Holders: 46
Total Shares Held: 24,835,415
3 Mo. Net Change: 4,868,743
# New Positions: 25
# Closed Positions: 8
# Increased Positions: 38
# Reduced Positions: 11
# Net Buyers: 27
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.